Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Cellectis S.A.
  6. News
  7. Summary
    ALCLS   FR0010425595

CELLECTIS S.A.

(ALCLS)
  Report
Real-time Euronext Paris  -  07:00 2022-12-08 am EST
2.138 EUR   +1.42%
12/06European Equities Largely Flat After Opening Lower in Tuesday Trading
MT
12/01Cellectis to Host a Live Webcast and Provide a Company Update on December 13, 2022
GL
11/30European Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CELLECTIS S.A.
12/01Cellectis to Host a Live Webcast and Provide a Company Update on December 13, 2022
GL
11/30Cellectis S A : Document AMF CP. 2022E873929
PU
11/24Cellectis S A : Document AMF CP. 2022E873261
PU
11/21Cellectis S A : Document AMF CP. 2022E872622
PU
11/18Cellectis S A : Document AMF CP. 2022E872470
PU
11/11Cellectis Publishes Manuscript in Frontiers Bioengineering and Biotechnology Unveiling ..
AQ
11/11Cellectis Presents Pre-Clinical Data on TALEN-edited Smart CAR T-cells Overcoming Key C..
AQ
11/10Cellectis Presents Pre-Clinical Data on TALEN®-edited Smart CAR T-cells Overcoming Key ..
GL
11/10Cellectis Presents Pre-Clinical Data on TALEN®-edited Smart CAR T-cells Overcoming Key ..
AQ
11/10Cellectis Publishes Manuscript in Frontiers Bioengineering and Biotechnology Unveiling ..
GL
11/04Transcript : Cellectis S.A., Q3 2022 Earnings Call, Nov 04, 2022
CI
11/03Cellectis S A : PRELIMINARY NOTE - Form 6-K
PU
11/03Cellectis S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep..
CI
11/03Cellectis Provides Business Update and Reports Financial Results for Third Quarter and ..
GL
11/03Cellectis Provides Business Update and Reports Financial Results for Third Quarter and ..
GL
More most relevant news
All news about CELLECTIS S.A.
12/06European Equities Largely Flat After Opening Lower in Tuesday Trading
MT
12/01Cellectis to Host a Live Webcast and Provide a Company Update on December 13, 2022
GL
11/30European Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
11/30Cellectis S A : Document AMF CP. 2022E873929
PU
11/24Cellectis S A : Document AMF CP. 2022E873261
PU
11/21Cellectis S A : Document AMF CP. 2022E872622
PU
11/18Cellectis S A : Document AMF CP. 2022E872470
PU
11/16European Equities Flat in Choppy Trade Wednesday as Geopolitical Tensions Weigh
MT
11/11Cellectis Publishes Manuscript in Frontiers Bioengineering and Biotechnology Unveiling ..
AQ
11/11Cellectis Presents Pre-Clinical Data on TALEN-edited Smart CAR T-cells Overcoming Key C..
AQ
More news
News in other languages on CELLECTIS S.A.
12/06Les actions européennes sont largement plates après avoir ouvert en baisse dans la négo..
12/01Cellectis organise un webcast en direct le 13 décembre 2022
11/30Les actions européennes en hausse en raison d'une légère baisse de l'inflation dans la ..
11/16Les actions européennes stagnent dans des échanges agités mercredi alors que les tensio..
11/11Séance de gala à Wall Street
11/11En direct des marchés : Teleperformance, Airbus, Richemont, Cellne..
11/10Les ADR européens grimpent en flèche alors que les marchés mondiaux réagissent aux donn..
11/10Cellectis : présente des données précliniques sur TALEN
11/10Cellectis présente des données précliniques sur des cellules « smart » CAR T éditées pa..
11/10Cellectis publie un article dans Frontiers Bioengineering and Biotechnology sur une str..
More news
Analyst Recommendations on CELLECTIS S.A.
05/24Goldman Sachs Adjusts Cellectis' Price Target to $2 from $3, Keeps Sell Rating
MT
05/18Baird Upgrades Cellectis to Outperform From Neutral
MT
05/13Barclays Lowers Cellectis S.A's Price Target to $7 From $9, Overweight Rating Maintaine..
MT
01/06Wells Fargo Downgrades Cellectis to Equalweight From Overweight; Price Target is $16
MT
2021JMP Securities Starts Cellectis at Market Outperform With $20 Price Target
MT
More recommendations
Press releases
12/01Cellectis to Host a Live Webcast and Provide a Company Update on December 13, 2022
GL
11/30Cellectis S A : Document AMF CP. 2022E873929
PU
11/24Cellectis S A : Document AMF CP. 2022E873261
PU
11/21Cellectis S A : Document AMF CP. 2022E872622
PU
11/18Cellectis S A : Document AMF CP. 2022E872470
PU
More press releases